A UK-Based Cost-Utility Analysis of Indacaterol, a Once-Daily Maintenance Bronchodilator for Patients With COPD, Using Real World Evidence on Resource Use
Applied Health Economics and Health Policy- Switzerland
doi 10.1007/s40258-013-0021-5
Full Text
Abstract
Available in
Date
March 26, 2013
Authors
Publisher
Springer Science and Business Media LLC